IL6 and paracoccidioidomycosis: In terms of medication, we believe that inhibition of the IL‐6/JAK2/STAT3 signaling pathway is a viable research direction, and related inhibitors have the potential to be used in the treatment of PCM to assist the current surgical treatment with high recurrence rate.